IL6 and osteosarcoma: Furthermore, Lagerweij et al. found that the systemic injection of human tumor EV-educated MSCs in mice bearing osteosarcoma xenografts strongly promoted cancer growth and metastasis formation by activating the IL-6/STAT3 signaling pathway [58].